Evaluation of Anti-diabetic Property on Streptozotocin-Induced Diabetic Rats

Area of Science:

• Endocrinology
• Toxicology
• Cell Biology

Background:

• Streptozotocin (STZ), a glucosamine-nitrosourea compound from Streptomyces achromogenes, is a diabetogenic agent.
• STZ selectively induces DNA strand breaks in pancreatic beta cells, triggering diabetes mellitus.
• The mechanism involves an initial insulin release followed by beta-cell destruction and hyperglycemia.

Purpose of the Study:

• To present a detailed methodology for the study of streptozotocin-induced diabetes.
• To outline the selection criteria for diabetic animal models.
• To describe the assessment of key diabetes-related parameters.

Main Methods:

• Selection of appropriate animal models for diabetes induction.
• Monitoring of blood glucose levels and body weight changes.
• Biochemical and histopathological analyses for disease characterization.

Main Results:

• STZ administration leads to specific beta-cell destruction.
• Characterization of the biphasic response to STZ, including insulin release and deficiency.
• Establishment of hyperglycemia as a consequence of beta-cell loss.

Conclusions:

• STZ is a reliable agent for inducing experimental diabetes mellitus.
• Comprehensive assessment of biochemical and histopathological parameters is crucial for understanding STZ-induced diabetes.
• The presented methods provide a framework for investigating diabetes pathogenesis and potential treatments.